Latest Teleflex Inc (TFX) Headlines
Teleflex Earnings In Retrospect: Up 1.7% in the Last 17 Days (TFX)
Comtex SmarTrend(R) - Mon Mar 10, 7:27AM CDT
Two weeks ago on February 21st, 2014 Teleflex (NYSE:TFX) reported earnings and analysts, on average, expected earnings of $1.28 on sales of $437.7 million. The company actually reported EPS of $1.36 on sales of $450.5 million, beating EPS estimates by $0.08 and beating revenue estimates by $12.9 million. Shares of Teleflex have climbed from $101.19 to $102.89, representing a gain of 1.7% since the company reported earnings 17 days ago.
Stock Price Movements, Official Platinum Sponsor Status, Conference Schedules, Appointments and Clinical Trial Results - Analyst Notes on Intuitive, Agilent, Teleflex, WuXi PharmaTech, and Pacira
PR Newswire - Wed Mar 05, 3:00PM CST
Editor Note: For more information about this release, please scroll to bottom.
Teleflex Beats on Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:50PM CST
Following the favorable earnings announcement, shares of Teleflex rose 0.8% till the last closing date.
Biotie: Change in the number of votes
Thomson Reuters ONE - Fri Feb 28, 12:51AM CST
BIOTIE THERAPIES CORP. Stock Exchange Release 28 February 2014 AT 8.50 AM
Tomorrow's Ex-Dividends To Watch: ACO, TFX, AVT
at The Street - Thu Feb 27, 9:00AM CST
ACO TFX AVT are going ex-dividend tomorrow, Friday, Feb. 28, 2014, 5:00 AM ET
Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018
M2 - Wed Feb 26, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rf662/portable_oxygen) has announced the addition of a new report "Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018" to their offering. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen. There has been a quantum improvement in the portable oxygen concentrator technology. Less weight, more power are the characteristics of the new portable units that begin to rival the larger home units. The huge jump in technology is illustrated by the effectiveness of the Inogen G3 and the about to be released VBox Trooper. Innovation started with Inogen One G3 and AirSep's LifeStyle are the less-than-10-pound battery-operated concentrator. AirSep has re-engineered the unit down to a 2 pound device. Newer portable oxygen concentrators can be used as multipurpose devices. Portable oxygen concentrator technology has been instantiated many times over, but in a most compelling manner by Inogen as the Inogen oxygen concentrator which represents a technological breakthrough. The Inogen One G3 is a complete departure from current mainstream technologies. It represents a shift away from standard large, bulky, stationary concentrator systems and inefficient, heavy, and impractical portable devices. Key Topics Covered: 1. Portable Oxygen Concentrator Market Description and Market Dynamics 2. Portable Oxygen Concentrator Market Shares and Forecasts 3. Portable Oxygen Concentrator Product Description 4. Oxygen Concentrator Technology 5. Respiratory Equipment Company Description Companies Mentioned : - Air Liquide - Braun and Company - CareFusion / Intermed Equipment - Chart Industries - Covidien - DeVilbiss Healthcare - Drive Medical - Dr?ger - Fanem - Fisher & Paykel Healthcare - GE Healthcare - Gardner Denver / Thomas Compressors - Getinge Group AB / Maquet - Graham Field - Hamilton Medical - Heinen & Loewenstein GmbH & Co - Inogen - Inova Labs - Invacare - Jiuxin Medical - Leistung Engineering - Longfian Scitech - Merits - Nidek Medical - O2 Concepts - OSI Systems - Philips Healthcare - ResMed Sleep Disordered Breathing (SDB) - Smiths Group plc / Smiths Medical - Teijin - Teleflex Incorporated / Teleflex Medical - Terumo - UltraNebs - VBox Trooper - Vitality Medical - Vygon For more information visit http://www.researchandmarkets.com/research/3r...ble_oxygen
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
Teleflex to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference
Business Wire - Tue Feb 25, 6:30AM CST
Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the J.P. Morgan Global High Yield & Leveraged Finance Conference at the Loews Miami Beach Hotel in Miami Beach, Florida, on Wednesday, February 26, 2014 at 11:00 a.m. (ET).
Teleflex to Present at Barclays Global Healthcare Conference
Business Wire - Tue Feb 25, 6:00AM CST
Benson F. Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at Barclays Global Healthcare Conference at the Loews Hotel in Miami, Florida, on Tuesday, March 11, 2014 at 3:15 p.m. (ET).
Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019
M2 - Mon Feb 24, 4:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zbkqd6/anesthesia_and) has announced the addition of the "Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019" report to their offering. Sophistication and persistent technological advances by respiratory and anesthesia device manufacturers have boosted the growth of this industry. The shift of patient preference from hospital care devices to home healthcare devices has accelerated the growth of this market and encouraged the provision of easy to use and portable devices that have paved a new way to revive this once mature market. According to the new estimates of World Health Organization, COPD is predicted to be become the third leading cause of death by 2030. Approximately 13.6 million adults were diagnosed with COPD in the U.S. alone in year 2012. The rise in geriatric population suffering from COPDs and Asthma are further expected to accelerate the growth of the respiratory devices market. In addition, the annual healthcare expenditures for asthma alone are estimated at $20.7 billion in the U.S. Thus, a rise in pulmonary diseases has helped in growth of this market. Moreover, rise in geriatric population has led to rise in the number of surgeries performed in the country. The American Society of Anestheologists (ASA) estimates 40 million anesthetics being administered each year in the U.S. alone. Thus rise in the number of surgeries coupled with rise in incidence of respiratory diseases have boosted the overall growth of this industry. Key Topics Covered: 1 Preface 2 Executive Summary 3 Global Anesthesia & Respiratory Devices Market Dynamics 4 Anesthesia And Respiratory Devices Market, By Segments 5 Anesthesia And Respiratory Devices Market, By Geography 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned: - Airsep - B Braun Melsungen AG - Carefusion Corporation - Covidien Plc - Draegerwerk AG & Co Kgaa - Getinge Group - Fisher & Paykel Healthcare - GE Healthcare - Philips Healthcare - Resmed - Smiths Medical - Teleflex Incorporated - Masimo Corporation For more information visit http://www.researchandmarkets.com/research/zb...thesia_and
Teleflex Set to Possibly Pullback After Yesterday's Rally of 3.60%
Comtex SmarTrend(R) - Fri Feb 21, 4:46PM CST
Teleflex (NYSE:TFX) traded in a range yesterday that spanned from a low of $100.36 to a high of $103.51. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $97.84 on volume of 987,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Teleflex Announces Quarterly Dividend
Business Wire - Fri Feb 21, 6:30AM CST
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 14, 2014 to shareholders of record at the close of business on March 4, 2014.
Teleflex Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Fri Feb 21, 6:00AM CST
--Fourth Quarter GAAP Diluted EPS of $0.78; Adjusted Diluted EPS of $1.36 up 18.3%
Concise Analysis of the International Urological Catheters Market
M2 - Wed Feb 19, 4:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/fkqjzk/urological) has announced the addition of the "Concise Analysis of the International Urological Catheters Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Urological Catheters in Thousand Units and US$ Million by the following Product Segments: - Dialysis Catheters (Hemodialysis, & Peritoneal) - Urinary Catheters (Foley, Intermittent, & External/Condom) The report profiles 68 companies including many key and niche players such as: - AngioDynamics, Inc. - Astra Tech, Inc. - B. Braun Melsungen AG - Boston Scientific Corp. - C. R. Bard, Inc. - Coloplast A/S - Cook Medical - Covidien PLC - Hollister, Inc. - Medline Industries, Inc. - Rochester Medical Corporation - Teleflex, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 68 (including Divisions/Subsidiaries - 82) - The United States (43) - Canada (4) - Japan (1) - Europe (21) - France (1) - Germany (4) - The United Kingdom (7) - Italy (1) - Rest of Europe (8) - Asia-Pacific (Excluding Japan) (12) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/fkqjzk/urological
Teleflex to Present at the Raymond James 35th Annual Institutional Investors Conference
Business Wire - Tue Feb 18, 6:00AM CST
Benson Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 35th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida, Tuesday, March 4, 2014 at 1:40 p.m. (ET).
Teleflex Incorporated unveils the Rusch DispoLED Laryngoscope Handle with single-use fiber optic technology to help improve clinical practice
M2 - Mon Feb 17, 6:30AM CST
Medical devices company Teleflex Incorporated (NYSE:TFX) on Friday revealed the market availability of the Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle to combat cross-contamination infection risk during intubation in a cost-neutral way.
Teleflex launches the Rusch(R) DispoLED(TM) Laryngoscope Handle
Business Wire - Fri Feb 14, 6:00AM CST
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch(R) DispoLED(TM) Single-Use Fiber Optic Laryngoscope Handle -- a cost-neutral* way to combat cross-contamination infection risk during intubation.
Teleflex Recalls Tracheal Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 1:50PM CST
Teleflex Medical has announced a worldwide voluntary recall of its ISIS HVT Tracheal Tube.
Teleflex Medical Announces Worldwide Voluntary Recall of ISIS(TM) HVT(TM) Tracheal Tube Cuffed with Subglottic Secretion Suction Port (with and without Preloaded Stylet)
Business Wire - Wed Feb 12, 4:00PM CST
Teleflex Medical Incorporated has announced a worldwide voluntary recall of its ISIS(TM) HVT(TM) Tracheal Tube Cuffed with Subglottic Secretion Suction Port (with and without Preloaded Stylet). This recall is being conducted because of complaints that the tracheal tube can kink during patient use. If a tracheal tube kinks, it can deprive the patient of adequate ventilation causing serious injury, including hypoxic injury and/or anoxia.
Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:30AM CST
The shares of Fluidigm Corporation fell over 6% on the day.This reverses the most recent uptrend for the company, as the stock is now up almost 8% since Jan 29.This scientific instruments company has seen a flat track record when it comes to current year estimate revisions.
Teleflex Earnings In Retrospect: Up 1.7% in the Last 17 Days (TFX)
Comtex SmarTrend(R) - Mon Mar 10, 7:27AM CDT
Two weeks ago on February 21st, 2014 Teleflex (NYSE:TFX) reported earnings and analysts, on average, expected earnings of $1.28 on sales of $437.7 million. The company actually reported EPS of $1.36 on sales of $450.5 million, beating EPS estimates by $0.08 and beating revenue estimates by $12.9 million. Shares of Teleflex have climbed from $101.19 to $102.89, representing a gain of 1.7% since the company reported earnings 17 days ago.
Stock Price Movements, Official Platinum Sponsor Status, Conference Schedules, Appointments and Clinical Trial Results - Analyst Notes on Intuitive, Agilent, Teleflex, WuXi PharmaTech, and Pacira
PR Newswire - Wed Mar 05, 3:00PM CST
Editor Note: For more information about this release, please scroll to bottom.
Teleflex Beats on Q4 Earnings, Shares Rise - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 28, 12:50PM CST
Following the favorable earnings announcement, shares of Teleflex rose 0.8% till the last closing date.
Biotie: Change in the number of votes
Thomson Reuters ONE - Fri Feb 28, 12:51AM CST
BIOTIE THERAPIES CORP. Stock Exchange Release 28 February 2014 AT 8.50 AM
Tomorrow's Ex-Dividends To Watch: ACO, TFX, AVT
at The Street - Thu Feb 27, 9:00AM CST
ACO TFX AVT are going ex-dividend tomorrow, Friday, Feb. 28, 2014, 5:00 AM ET
Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018
M2 - Wed Feb 26, 6:05AM CST
Research and Markets (http://www.researchandmarkets.com/research/3rf662/portable_oxygen) has announced the addition of a new report "Concise Analysis of the International Portable Oxygen Concentrators - Forecasts to 2018" to their offering. Worldwide markets are poised to achieve continuing growth as the aging population worldwide needs homecare oxygen treatment. Older people develop COPD and other respiratory conditions where oxygen is able to improve the quality of the life in a dramatic manner. Portable devices have become affordable and support a mobile lifestyle even while on oxygen. There has been a quantum improvement in the portable oxygen concentrator technology. Less weight, more power are the characteristics of the new portable units that begin to rival the larger home units. The huge jump in technology is illustrated by the effectiveness of the Inogen G3 and the about to be released VBox Trooper. Innovation started with Inogen One G3 and AirSep's LifeStyle are the less-than-10-pound battery-operated concentrator. AirSep has re-engineered the unit down to a 2 pound device. Newer portable oxygen concentrators can be used as multipurpose devices. Portable oxygen concentrator technology has been instantiated many times over, but in a most compelling manner by Inogen as the Inogen oxygen concentrator which represents a technological breakthrough. The Inogen One G3 is a complete departure from current mainstream technologies. It represents a shift away from standard large, bulky, stationary concentrator systems and inefficient, heavy, and impractical portable devices. Key Topics Covered: 1. Portable Oxygen Concentrator Market Description and Market Dynamics 2. Portable Oxygen Concentrator Market Shares and Forecasts 3. Portable Oxygen Concentrator Product Description 4. Oxygen Concentrator Technology 5. Respiratory Equipment Company Description Companies Mentioned : - Air Liquide - Braun and Company - CareFusion / Intermed Equipment - Chart Industries - Covidien - DeVilbiss Healthcare - Drive Medical - Dr?ger - Fanem - Fisher & Paykel Healthcare - GE Healthcare - Gardner Denver / Thomas Compressors - Getinge Group AB / Maquet - Graham Field - Hamilton Medical - Heinen & Loewenstein GmbH & Co - Inogen - Inova Labs - Invacare - Jiuxin Medical - Leistung Engineering - Longfian Scitech - Merits - Nidek Medical - O2 Concepts - OSI Systems - Philips Healthcare - ResMed Sleep Disordered Breathing (SDB) - Smiths Group plc / Smiths Medical - Teijin - Teleflex Incorporated / Teleflex Medical - Terumo - UltraNebs - VBox Trooper - Vitality Medical - Vygon For more information visit http://www.researchandmarkets.com/research/3r...ble_oxygen
Progress Watch Corp. to Enter Social/Content Marketing Arena
Marketwire - Tue Feb 25, 9:13AM CST
Progress Watch Corporation (PINKSHEETS: PROW) announced that it will enter the social/ content marketing arena. With more than one billion smart phone users and 1.7 billion expected by 2017, this move from its traditional core business line mechanical movement manufacturing and watch supply businesses) is expected to develop new revenue streams for the company, especially in the area of social/content marketing. Companies will have the ability to target specific markets to stream branded messages.
Teleflex to Present at the J.P. Morgan Global High Yield & Leveraged Finance Conference
Business Wire - Tue Feb 25, 6:30AM CST
Jake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at the J.P. Morgan Global High Yield & Leveraged Finance Conference at the Loews Miami Beach Hotel in Miami Beach, Florida, on Wednesday, February 26, 2014 at 11:00 a.m. (ET).
Teleflex to Present at Barclays Global Healthcare Conference
Business Wire - Tue Feb 25, 6:00AM CST
Benson F. Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE:TFX), is scheduled to speak at Barclays Global Healthcare Conference at the Loews Hotel in Miami, Florida, on Tuesday, March 11, 2014 at 3:15 p.m. (ET).
Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019
M2 - Mon Feb 24, 4:58AM CST
Research and Markets (http://www.researchandmarkets.com/research/zbkqd6/anesthesia_and) has announced the addition of the "Concise Analysis of the International Anesthesia and Respiratory Devices Market - Forecast to 2019" report to their offering. Sophistication and persistent technological advances by respiratory and anesthesia device manufacturers have boosted the growth of this industry. The shift of patient preference from hospital care devices to home healthcare devices has accelerated the growth of this market and encouraged the provision of easy to use and portable devices that have paved a new way to revive this once mature market. According to the new estimates of World Health Organization, COPD is predicted to be become the third leading cause of death by 2030. Approximately 13.6 million adults were diagnosed with COPD in the U.S. alone in year 2012. The rise in geriatric population suffering from COPDs and Asthma are further expected to accelerate the growth of the respiratory devices market. In addition, the annual healthcare expenditures for asthma alone are estimated at $20.7 billion in the U.S. Thus, a rise in pulmonary diseases has helped in growth of this market. Moreover, rise in geriatric population has led to rise in the number of surgeries performed in the country. The American Society of Anestheologists (ASA) estimates 40 million anesthetics being administered each year in the U.S. alone. Thus rise in the number of surgeries coupled with rise in incidence of respiratory diseases have boosted the overall growth of this industry. Key Topics Covered: 1 Preface 2 Executive Summary 3 Global Anesthesia & Respiratory Devices Market Dynamics 4 Anesthesia And Respiratory Devices Market, By Segments 5 Anesthesia And Respiratory Devices Market, By Geography 6 Competitive Landscape 7 Recommendations 8 Company Profiles Companies Mentioned: - Airsep - B Braun Melsungen AG - Carefusion Corporation - Covidien Plc - Draegerwerk AG & Co Kgaa - Getinge Group - Fisher & Paykel Healthcare - GE Healthcare - Philips Healthcare - Resmed - Smiths Medical - Teleflex Incorporated - Masimo Corporation For more information visit http://www.researchandmarkets.com/research/zb...thesia_and
Teleflex Set to Possibly Pullback After Yesterday's Rally of 3.60%
Comtex SmarTrend(R) - Fri Feb 21, 4:46PM CST
Teleflex (NYSE:TFX) traded in a range yesterday that spanned from a low of $100.36 to a high of $103.51. Yesterday, the shares gained 3.6%, which took the trading range above the 3-day high of $97.84 on volume of 987,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Teleflex Announces Quarterly Dividend
Business Wire - Fri Feb 21, 6:30AM CST
Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable March 14, 2014 to shareholders of record at the close of business on March 4, 2014.
Teleflex Reports Fourth Quarter and Full Year 2013 Results
Business Wire - Fri Feb 21, 6:00AM CST
--Fourth Quarter GAAP Diluted EPS of $0.78; Adjusted Diluted EPS of $1.36 up 18.3%
Concise Analysis of the International Urological Catheters Market
M2 - Wed Feb 19, 4:52AM CST
Research and Markets (http://www.researchandmarkets.com/research/fkqjzk/urological) has announced the addition of the "Concise Analysis of the International Urological Catheters Market" report to their offering. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for the period 2010 through 2018. Also, a six-year historic analysis is provided for these markets. This report analyzes the worldwide markets for Urological Catheters in Thousand Units and US$ Million by the following Product Segments: - Dialysis Catheters (Hemodialysis, & Peritoneal) - Urinary Catheters (Foley, Intermittent, & External/Condom) The report profiles 68 companies including many key and niche players such as: - AngioDynamics, Inc. - Astra Tech, Inc. - B. Braun Melsungen AG - Boston Scientific Corp. - C. R. Bard, Inc. - Coloplast A/S - Cook Medical - Covidien PLC - Hollister, Inc. - Medline Industries, Inc. - Rochester Medical Corporation - Teleflex, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. For information on site licence pricing please click on Enquire before buying. Key Topics Covered: I. Introduction, Methodology & Product Definitions II. Executive Summary III. Market 1. The United States 2. Canada 3. Japan 4. Europe 5. Asia-Pacific 6. The Middle East 7. Latin America IV. Competitive Landscape Total Companies Profiled: 68 (including Divisions/Subsidiaries - 82) - The United States (43) - Canada (4) - Japan (1) - Europe (21) - France (1) - Germany (4) - The United Kingdom (7) - Italy (1) - Rest of Europe (8) - Asia-Pacific (Excluding Japan) (12) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/fkqjzk/urological
Teleflex to Present at the Raymond James 35th Annual Institutional Investors Conference
Business Wire - Tue Feb 18, 6:00AM CST
Benson Smith, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 35th Annual Institutional Investors Conference at the JW Marriott Grande Lakes in Orlando, Florida, Tuesday, March 4, 2014 at 1:40 p.m. (ET).
Teleflex Incorporated unveils the Rusch DispoLED Laryngoscope Handle with single-use fiber optic technology to help improve clinical practice
M2 - Mon Feb 17, 6:30AM CST
Medical devices company Teleflex Incorporated (NYSE:TFX) on Friday revealed the market availability of the Rusch DispoLED Single-Use Fiber Optic Laryngoscope Handle to combat cross-contamination infection risk during intubation in a cost-neutral way.
Teleflex launches the Rusch(R) DispoLED(TM) Laryngoscope Handle
Business Wire - Fri Feb 14, 6:00AM CST
Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, has announced the launch of the Rusch(R) DispoLED(TM) Single-Use Fiber Optic Laryngoscope Handle -- a cost-neutral* way to combat cross-contamination infection risk during intubation.
Teleflex Recalls Tracheal Tube - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Feb 13, 1:50PM CST
Teleflex Medical has announced a worldwide voluntary recall of its ISIS HVT Tracheal Tube.
Teleflex Medical Announces Worldwide Voluntary Recall of ISIS(TM) HVT(TM) Tracheal Tube Cuffed with Subglottic Secretion Suction Port (with and without Preloaded Stylet)
Business Wire - Wed Feb 12, 4:00PM CST
Teleflex Medical Incorporated has announced a worldwide voluntary recall of its ISIS(TM) HVT(TM) Tracheal Tube Cuffed with Subglottic Secretion Suction Port (with and without Preloaded Stylet). This recall is being conducted because of complaints that the tracheal tube can kink during patient use. If a tracheal tube kinks, it can deprive the patient of adequate ventilation causing serious injury, including hypoxic injury and/or anoxia.
Fluidigm Corporation (FLDM) Crumbles: Stock Falls by 6.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Feb 10, 7:30AM CST
The shares of Fluidigm Corporation fell over 6% on the day.This reverses the most recent uptrend for the company, as the stock is now up almost 8% since Jan 29.This scientific instruments company has seen a flat track record when it comes to current year estimate revisions.
